<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02992275</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00072630</org_study_id>
    <nct_id>NCT02992275</nct_id>
  </id_info>
  <brief_title>NMES to Improve Hip Abductor Strength and Balance</brief_title>
  <acronym>IMAGINE+NMES</acronym>
  <official_title>Neuromuscular Electrical Stimulation as an Adjunct to Improve Hip Abductor Muscle Quality and Reduce Fall Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baltimore VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baltimore VA Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the addition of neuromuscular electrical stimulation (NMES) on the&#xD;
      hip abductors during strength training and a fall prevention program for improving muscle&#xD;
      strength and improving balance. All individuals in this study will receive NMES to their hip&#xD;
      abductors and will participate in a fall reduction program.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Falls are a leading cause of disability in older adults. Decreased lower extremity muscle&#xD;
      mass and strength contribute to balance and mobility limitations. Our more recent work also&#xD;
      suggests that in addition to the traditional targets of muscle mass of the thigh and leg&#xD;
      muscles, dysfunction of the hip abductors may contribute to balance and mobility limitations&#xD;
      resulting in increased fall risk. Older adults with impaired hip abductor muscles demonstrate&#xD;
      increased amounts of intramuscular fat (IMAT) in and around the muscles, decreased hip&#xD;
      abductor strength, lower balance scores, increased gait variability (a predictor of future&#xD;
      falls), and poor stepping mechanics when recovering from a balance perturbation. Increased&#xD;
      IMAT and muscle dysfunction of the hip abductors may contribute to poor hip abductor muscle&#xD;
      recruitment and make changing these muscle during a traditional intervention difficult.&#xD;
      Neuromuscular electrical stimulation (NMES) is one method to improve muscle mass, strength&#xD;
      and quality in older adults, but has not traditionally been used on the hip abductors. We&#xD;
      propose that a targeted multimodality balance intervention (MMBI) focused on the lateral and&#xD;
      diagonal stepping and hip abductor strengthening when combined with NMES will result in&#xD;
      improvements in mobility and balance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mobility</measure>
    <time_frame>6 months</time_frame>
    <description>Mobility will be measured with the use of the mini-BesTest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Balance</measure>
    <time_frame>6-months</time_frame>
    <description>Balance will be measured with the four-square step test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Strength</measure>
    <time_frame>6-months</time_frame>
    <description>Muscle strength will be measured as hip abductor strength quantified by use of a biodex</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Postural Balance</condition>
  <arm_group>
    <arm_group_label>NMES + MMBI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromuscular electrical stimulation applied to hip abductors along with participation in a multi-modality balance intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuromuscular electrical stimulation (NMES)</intervention_name>
    <description>Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 24 weeks</description>
    <arm_group_label>NMES + MMBI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multi-Modality Balance Intervention (MMBI)</intervention_name>
    <description>Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 24 weeks</description>
    <arm_group_label>NMES + MMBI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Mobility and balance limitations as demonstrated by a self-reported fall within the past&#xD;
        year or requiring greater than 8 seconds to complete the 4-square step test&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Cardiovascular Risks: Poorly controlled hypertension (&gt;160/100); or patient report of:&#xD;
             symptomatic angina at rest or during exercise, syncope without known resolution of&#xD;
             cause, or a significant coronary event (such as a MI) in the past six months&#xD;
&#xD;
          2. COPD requiring home oxygen&#xD;
&#xD;
          3. Contraindications to resistance training, including a self-reported history of&#xD;
             intracranial or retinal bleeding in the last year or Diabetes with active&#xD;
             proliferative retinopathy&#xD;
&#xD;
          4. Patient report of significant spinal stenosis that would limit participation in the&#xD;
             exercise intervention&#xD;
&#xD;
          5. Non-ambulatory mobility status or a transtibial or transfemoral amputation&#xD;
&#xD;
          6. Dementia (on medical record review or mini-mental status exam score &lt;24).&#xD;
&#xD;
          7. Other severe medical illness or condition that would preclude safe participation in&#xD;
             the study as determined by the study team&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Les Katzel, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Director Baltmore GRECC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Odessa Addison, DPT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Scientist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baltimore VA Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 12, 2016</study_first_submitted>
  <study_first_submitted_qc>December 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2016</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baltimore VA Medical Center</investigator_affiliation>
    <investigator_full_name>Odessa Addison</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>Muscle</keyword>
  <keyword>Skeletal/physiopathology</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

